Assignee
GMAX BIOPHARM LLC
CN·11 granted patents·2 pending applications·7 citations·filing 2014–2023
Top patents by PatentIndex Score
13 records- 0180US10869927B2Human endothelin receptor antibody and use thereofGMAX BIOPHARM LLC·Filed 2019·Granted Dec 22, 2020·1 cites·9 claims
- 0279US10253103B2Antibody specifically binding to GLP-1R and fusion protein thereof with GLP-1GMAX BIOPHARM LLC·Filed 2018·Granted Apr 9, 2019·2 cites·31 claims
- 0378US10376581B2Human endothelin receptor antibody and use thereofGMAX BIOPHARM LLC·Filed 2016·Granted Aug 13, 2019·2 cites·10 claims
- 0476US11780916B2GIPR antibody and GLP-1 fusion protein thereof, and pharmaceutical composition and application thereofGMAX BIOPHARM LLC·Filed 2019·Granted Oct 10, 2023·1 cites·27 claims
- 0574US12594334B2ETAR antibody, and pharmaceutical compositions and use thereofGMAX BIOPHARM LLC·Filed 2023·Granted Apr 7, 2026·0 cites·21 claims
- 0670US11712470B2Human endothelin receptor antibody and use thereofGMAX BIOPHARM LLC·Filed 2020·Granted Aug 1, 2023·0 cites·9 claims
- 0770US10059773B2Antibody specifically binding to GLP-1 R and fusion protein thereof with GLP-1GMAX BIOPHARM LLC·Filed 2014·Granted Aug 28, 2018·1 cites·17 claims
- 0853US11542336B2GCGR antibody and GLP-1 fusion protein thereof, pharmaceutical composition thereof and application thereofGMAX BIOPHARM LLC·Filed 2019·Granted Jan 3, 2023·0 cites·7 claims
- 0952US2022411520A1Gipr antibody and fusion protein between same and glp-1, and pharmaceutical composition and application thereofGMAX BIOPHARM LLC·Filed 2020·Application pending·0 cites
- 1051US12473369B2Fusion protein of anti-eta antibody and tgf-beta trap and pharmaceutical composition and application thereof in method of treatmentGMAX BIOPHARM LLC·Filed 2020·Granted Nov 18, 2025·0 cites·19 claims
- 1149US2019134196A1Etar antibody, and pharmaceutical compositions and use thereofGMAX BIOPHARM LLC·Filed 2017·Application pending·0 cites
- 1246US12221488B2APJ antibody, fusion protein thereof with Elabela, and pharmaceutical compositions and use thereofus01GMAX BIOPHARM LLC·Filed 2019·Granted Feb 11, 2025·0 cites·12 claims
- 1335US10485870B2Stable pharmaceutical solution formulation of GLP-1R antibody fusion proteinGMAX BIOPHARM LLC·Filed 2016·Granted Nov 26, 2019·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when GMAX BIOPHARM LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →